查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1919307

奈米孔单分子定序仪市场：按产品类型、经营模式、应用和最终用户划分－2026-2032年全球预测

Nanopore Single Molecule Sequencer Market by Product Type, Business Model, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年奈米孔单分子定序仪市值为 8.1294 亿美元，预计到 2026 年将成长至 8.7992 亿美元，到 2032 年预计将达到 12.4867 亿美元，复合年增长率为 6.32%。

关键市场统计数据
基准年 2025 8.1294亿美元
预计年份：2026年 8.7992亿美元
预测年份 2032 12.4867亿美元
复合年增长率 (%) 6.32%

本文简要介绍了单分子奈米孔定序如何改变实验室工作流程，实现长读长分析，并迅速扩大转化研究的机会。

本文将奈米孔单分子定序定位为一项催化技术，它将重塑科学研究和临床工作流程中的分子分析方式。奈米孔技术无需扩增即可对天然核酸进行即时长读长定定序，在结构变异检测、表观遗传分析、直接RNA定序和快速病原体鑑定方面具有独特的优势。孔道化学、感测器电子学和演算法碱基辨识方面的进步，共同提高了定序的准确性、通量和易用性，从而促进了该技术在专业基因组学实验室之外的更广泛应用。

奈米孔定序系统中推动快速演进和策略调整的关键技术、营运和商业性转折点

奈米定序领域正经历技术、操作和商业性等多个层面的变革。在技​​术层面，孔道化学、马达蛋白和讯号处理技术的进步缩小了奈米孔定序与其他定序方法之间的准确性差距，并解锁了诸如直接分析甲基化和RNA修饰等独特功能。这些进步与碱基辨识和纠错演算法的改进相辅相成，降低了资讯处理负担，使长读长定序资料更适用于下游分析。

美国近期关税政策的变化对奈米孔定序价值定序的短期采购压力和长期供应链韧性措施都产生了影响。

美国2025年实施的关税调整的累积影响，为奈米孔定序价值定序带来了复杂的挑战，也促使各方采取相应的策略应对措施。进口零件和设备的关税相关成本上涨，增加了实验室营运商和服务供应商的采购成本，对采购週期和资本支出核准造成了短期压力。为因应这些挑战，有些製造商加快了供应链在地化和策略采购，以降低风险；而有些製造商则选择暂时承担部分成本，以维繫与关键客户的关係。

将产品层级、应用领域、最终用户需求和商业经营模式连结起来的可操作細項分析，有助于确定策略投资的优先顺序。

细分市场分析揭示了技术重点领域、临床应用和商业性指南，从而指导策略规划和产品优先排序。根据产品类型，市场被分为三个部分：耗材、仪器和软体。耗材进一步细分为流通池和试剂盒。仪器分为网格、微型和专业仪器。软体分为分析软体和云端解决方案。这种产品层面的细分錶明，持续的耗材和分析软体构成了商业模式的核心，而仪器的分级则满足了不同的处理能力和部署需求。

区域采用模式和监管趋势塑造了美洲、欧洲、中东和非洲以及亚太市场差异化的商业性扩张策略

区域趋势揭示了不同的技术采纳模式、监管路径和商业化路径，这些因素会影响策略性市场进入和扩张决策。在美洲，强大的学术网络、充足的创业投资资金和成熟的生物技术丛集正在加速技术采纳，尤其是在转化研究和临床试验开发领域。北美临床实验室和生物製药公司往往是早期采用者，这得益于它们检验和规模化生产能力；而可现场部署的应用则受益于成熟的公共卫生和国防采购管道。

在奈米孔定序系统中，竞争与合作趋势评估包括整合解决方案、检验的工作流程和以客户为中心的服务。

奈米孔定序生态系的竞争动态呈现出成熟领导者、快速创新者和不断壮大的专业伙伴三者并存的态势。主要仪器供应商优先投资于硬体的迭代改进、耗材生态系统的开发以及分析技术的研发，以提升易用性和临床应对力。同时，专业试剂生产商和新兴企业则专注于开发优化的化学方法和试剂盒，以提高通量、准确性和样本製备流程。软体供应商和云端分析供应商正在建立模组化、扩充性的平台，支援碱基识别、变异检测、甲基化检测和整合式视觉化，从而加快终端用户获得分析结果的速度。

经营团队在推动奈米孔定序市场应用、增强韧性和持续创造价值方面的具体策略重点

业界领导者应采取一系列切实可行、影响深远的倡议，在把握新机会的同时管控营运风险。首先，应优先制定模组化产品蓝图，将设备等级与清晰的应用路径和检验的工作流程相匹配，使客户能够根据自身用例选择合适的平台功能。其次，应拓展耗材生态系统和订阅软体产品，以推动经常性收入成长并加深客户参与，同时确保价格透明和供应承诺可预测。

采用透明的多方法研究途径，结合一手访谈、技术文献回顾和三角验证分析，帮助您做出自信的策略决策。

本调查方法融合了定性和定量方法，旨在最大限度地减少偏差，确保透明度，并得出可靠且可重复的结论。主要研究包括对设备工程师、实验室主任、采购人员、监管专家和高级研发主管进行结构化访谈，以获取有关技术性能、检验挑战和采购行为的第一手资料。此外，还对同行评审文献、检验研究和会议论文进行了技术审查，以确保研究结果有科学检验。

策略概述重点介绍奈米孔定序技术的优势、关键营运挑战以及有效将其纳入主流所需的生态系统利用策略。

总之，奈米孔单分子定序在更广泛的基因组学领域占据着一个独特且不断扩展的细分市场，其特点在于长读长分析、直接修饰检测和即时数据生成等方面的独特能力。技术的成熟、多样化的仪器产品组合以及不断发展的软体生态系统正在降低其在科研、临床和现场应用领域的普及门槛。然而，成功的规模化应用需要生态系层面的协调配合。具体而言，它需要稳健的耗材供应链、检验的工作流程、符合监管要求的准备以及能够为最终用户带来可预测价值的引人注目的商业模式。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的奈米孔单分子定序仪市场

  • 消耗品
    • 流动池
    • 成套工具
  • 装置
    • 葛莱迪翁
    • 小小兵
    • 鲷
  • 软体
    • 分析软体
    • 云端解决方案

9. 依经营模式分類的奈米孔单分子定序仪市场

  • 产品销售
  • 服务协定

第十章 奈米孔单分子定序仪市场（依应用划分）

  • 临床诊断
  • 表观基因
  • 基因组学
  • 总体基因体学
  • 转录组学

第十一章 依最终用户分類的奈米孔单分子定序仪市场

  • 学术和政府机构
  • 生物製药和製药公司
  • 临床检查室
  • CRO（受託研究机构）

12. 奈米孔单分子定序仪市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 奈米孔单分子定序仪市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国奈米孔单分子定序仪市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章美国奈米孔单分子定序仪市场

第十六章：中国奈米孔单分子定序仪市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Direct Genomics Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Genapsys, Inc.
  • Hitachi High-Technologies Corporation
  • Illumina, Inc.
  • Microsynth AG
  • Nabsys, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Quantum Biosystems Inc.
  • SeqLL Inc.
  • Stratos Genomics, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation
Product Code: MRR-F14BA1B341A4

The Nanopore Single Molecule Sequencer Market was valued at USD 812.94 million in 2025 and is projected to grow to USD 879.92 million in 2026, with a CAGR of 6.32%, reaching USD 1,248.67 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 812.94 million
Estimated Year [2026] USD 879.92 million
Forecast Year [2032] USD 1,248.67 million
CAGR (%) 6.32%

A concise primer on how single-molecule nanopore sequencing is transforming laboratory workflows, enabling long-read insights and expanding translational opportunities at pace

The introduction frames nanopore single-molecule sequencing as a catalytic technology reshaping molecular analysis across research and clinical workflows. Nanopore approaches enable real-time, long-read sequencing of native nucleic acids without amplification, delivering unique capabilities for structural variation detection, epigenetic profiling, direct RNA sequencing, and rapid pathogen identification. Advances in pore chemistry, sensor electronics, and algorithmic basecalling have collectively improved accuracy, throughput, and usability, encouraging broader adoption beyond specialist genomics laboratories.

In parallel, instrument miniaturization and cloud-enabled analytics are lowering barriers to entry for distributed testing and field-deployable applications. This shift supports new use cases in clinical diagnostics, public health surveillance, environmental monitoring, and point-of-care investigation. As a result, stakeholders ranging from academic research centers to commercial biopharma and clinical laboratories are re-evaluating their sequencing infrastructure strategies to incorporate nanopore platforms where long reads, rapid turnaround, and direct modification detection confer distinct advantages.

Looking ahead, the interplay of instrument innovation, consumable economics, and software maturity will determine how rapidly and broadly nanopore sequencing transitions from a specialized capability into a mainstream tool. Strategic investments in interoperability, quality assurance, and regulatory validation will accelerate clinical translation, while collaborative ecosystems of instrument providers, consumable manufacturers, and informatics developers will define the shape of commercial opportunity.

Key technological, operational, and commercial inflection points driving rapid evolution and strategic realignment within the nanopore sequencing ecosystem

The landscape for nanopore sequencing is experiencing multiple transformative shifts that are simultaneously technological, operational, and commercial. Technologically, improvements in pore chemistry, motor proteins, and signal processing have narrowed the accuracy gap with other sequencing modalities while unlocking unique capabilities for direct methylation and RNA modification analysis. These advancements are complemented by algorithmic progress in basecalling and error correction, which together reduce the informatics burden and make long-read outputs more actionable for downstream interpretation.

Operationally, instrument form factors have diversified, ranging from portable devices suitable for fieldwork to higher-throughput platforms designed for centralized laboratories. This diversification is reshaping procurement strategies and enabling hybrid deployment models where point-of-need sequencing feeds into centralized analysis pipelines. Commercially, new business models are emerging that combine instrument sales with recurring consumable revenue and cloud-based software subscriptions, driving predictable revenue streams and tighter customer lock-in. Regulatory progress is also significant; as validation studies and reference standards accumulate, clinical adoption pathways become clearer, accelerating the translation of nanopore assays into diagnostic workflows.

Consequently, ecosystem dynamics are shifting to favor integrative partnerships across hardware, reagents, and software, with a growing premium placed on interoperability, quality control, and end-to-end service delivery. These shifts are creating strategic inflection points for incumbents and new entrants alike, prompting reevaluation of product roadmaps, go-to-market strategies, and partnerships that can scale innovation responsibly and commercially.

How recent US tariff policy shifts drove short-term procurement pressures and long-term supply chain resilience measures across the nanopore sequencing value chain

The cumulative impact of United States tariff adjustments in 2025 created a complex set of headwinds and strategic responses across the nanopore sequencing value chain. Tariff-related cost increases for imported components and instruments raised procurement costs for laboratory operators and service providers, prompting near-term pressure on purchasing cycles and capital expenditure approvals. In response, some manufacturers accelerated localization of supply chains and strategic sourcing to mitigate exposure, while others absorbed costs temporarily to preserve customer relationships in key accounts.

Beyond direct price effects, tariffs influenced partner negotiations and contracting practices. Service organizations and distributors revisited margin structures and contractual clauses to account for potential future policy volatility, and procurement teams incorporated tariff contingencies into purchase planning. These adjustments also contributed to a renewed focus on operational resilience, including dual-sourcing strategies, inventory optimization, and increased scrutiny of upstream suppliers' geographic exposure.

Importantly, the tariff effects catalyzed strategic investment in domestic manufacturing capacity and expanded collaboration with regional suppliers. While such transitions require lead time and capital, they reduce long-term policy risk and can shorten supply chains, improving responsiveness to demand fluctuations. Ultimately, the tariff environment emphasized the importance of agility and scenario planning for organizations operating in the nanopore sequencing market, reinforcing the need to balance cost management with continuity of supply and service quality.

Actionable segmentation intelligence linking product tiers, application domains, end-user demands, and commercial business models to prioritize strategic investments

Segmentation analysis illuminates areas of technological focus, clinical applicability, and commercial targeting that inform strategic planning and product prioritization. Based on Product Type, market is studied across Consumable, Instrument, and Software. The Consumable is further studied across Flow Cells and Kits. The Instrument is further studied across Gridion, Minion, and Promethion. The Software is further studied across Analysis Software and Cloud Solutions. This product-level breakdown underscores that recurring consumables and analytical software are central to commercial models, while instrument tiers address diverse throughput and deployment needs.

Based on Application, market is studied across Clinical Diagnostics, Epigenomics, Genomics, Metagenomics, and Transcriptomics. The breadth of applications highlights how nanopore sequencing serves both discovery-driven research and translational use cases, with particular strengths in structural variant detection, long-range phasing, direct RNA analysis, and methylation mapping. Based on End User, market is studied across Academic Government, Biopharma Pharma, Clinical Laboratories, and Contract Research Organizations. These user segments exhibit distinct procurement cycles, validation demands, and service expectations, requiring tailored engagement strategies and product configurations.

Based on Business Model, market is studied across Product Sales and Service Contracts. Business model choices shape revenue predictability and customer relationships; product sales enable rapid scale, while service contracts and consumable subscriptions create ongoing touchpoints and increase lifetime value. Integrating product, application, end-user, and business model segmentation offers a coherent lens for prioritizing investments, designing pricing, and structuring partnerships.

Regional adoption patterns and regulatory dynamics that shape differentiated strategies for commercial expansion across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics reveal differentiated adoption patterns, regulatory trajectories, and commercialization pathways that influence strategic market entry and expansion decisions. In the Americas, strong academic networks, robust venture funding, and established biotech clusters accelerate technology adoption, especially for translational research and clinical assay development. North American clinical laboratories and biopharma organizations often act as early adopters due to their capacity for validation and scale-up, while field-deployable applications benefit from established public health and defense procurement channels.

In Europe, Middle East & Africa, diverse regulatory regimes and varying infrastructure maturity drive a heterogeneous adoption landscape. Western European markets show strong interest in clinical validation and integrated care pathways, while emerging markets within the region are beginning to leverage nanopore platforms for public health surveillance and agricultural genomics. Regional collaboration frameworks and cross-border research consortia often shape procurement and implementation strategies.

In Asia-Pacific, high-volume diagnostic demand, large-scale sequencing initiatives, and significant manufacturing capabilities create unique opportunities. Rapid digitalization and investments in local production capacity are accelerating adoption, while national genomics programs and public health priorities provide demand signals for both portable and high-throughput solutions. Across regions, localized partnerships, compliance strategies, and support infrastructures remain decisive factors in commercial success.

Competitive and partnership dynamics that reward integrative solutions, validated workflows, and customer-centric services within the nanopore sequencing ecosystem

Competitive dynamics in the nanopore sequencing ecosystem reflect a mixture of incumbent leadership, rapid innovation, and an expanding universe of specialist partners. Leading instrument providers have prioritized iterative hardware improvements, development of consumable ecosystems, and investment in analytics to enhance usability and clinical readiness. At the same time, specialized reagent companies and start-ups are focusing on optimized chemistries and kits that improve throughput, accuracy, and sample preparation workflows. Software vendors and cloud analytics providers are building modular, scalable platforms that support basecalling, variant calling, methylation detection, and integrated visualization, thereby reducing time-to-insight for end users.

Partnerships between instrument manufacturers and informatics companies are increasingly common, enabling bundled solutions that address laboratory validation and regulatory documentation needs. Contract research organizations and clinical laboratories are forming preferred supplier relationships with platform vendors to streamline assay development and diagnostic validation. Additionally, new entrants focused on niche applications-such as environmental metagenomics, rapid infectious disease testing, or agricultural genomics-are carving sustainable positions by aligning product features with specific workflow requirements.

The competitive landscape rewards organizations that couple technical excellence with strong customer support, validated workflows, and an ecosystem of compatible consumables and software. Strategic alliances, co-development agreements, and service offerings that lower the barrier to adoption will remain critical differentiators in a market driven by both technological progress and practical implementation demands.

Practical strategic priorities for executives to accelerate adoption, strengthen resilience, and capture recurring value in the nanopore sequencing market

Industry leaders should pursue a set of pragmatic, high-impact actions to capitalize on emerging opportunities while managing operational risk. First, prioritize modular product roadmaps that align instrument tiers with clear application pathways and validated workflows, enabling customers to match platform capabilities to their use cases. Second, expand consumable ecosystems and subscription-based software offerings to establish recurring revenue and deeper customer engagement, while ensuring transparent pricing and predictable supply commitments.

Third, invest in local and regional supply chain diversification to mitigate geopolitical and tariff-related risks; dual-sourcing of critical components and strategic manufacturing partnerships will reduce vulnerability to policy shifts. Fourth, accelerate clinical validation efforts and generate peer-reviewed evidence to support regulatory submissions and payer discussions, thereby smoothing the path to diagnostic adoption. Fifth, develop comprehensive service and training programs that shorten time-to-value for customers, including curated onboarding, remote support, and turnkey assay development services.

Finally, forge targeted alliances with academic centers, biopharma innovators, and public health agencies to co-develop use cases and demonstrate impact at scale. By combining technical advancement with operational excellence and ecosystem-building, leaders can translate innovation into sustainable commercial growth and meaningful clinical or public health outcomes.

A transparent, multi-method research approach combining primary interviews, technical literature synthesis, and triangulated analysis to support confident strategic decisions

The research methodology integrates qualitative and quantitative approaches designed to yield robust, reproducible insights while minimizing bias and ensuring transparency. Primary research included structured interviews with instrument engineers, laboratory directors, procurement leads, regulatory experts, and senior R&D executives to capture firsthand perspectives on technology performance, validation challenges, and purchasing behavior. These interviews were supplemented by technical reviews of peer-reviewed literature, validation studies, and conference proceedings to ground findings in validated science.

Secondary research canvassed public company filings, patent disclosures, regulatory filings, and technical white papers to map innovation trajectories and supplier strategies. Data triangulation techniques were used to reconcile insights from interviews, literature, and corporate documentation, ensuring that conclusions reflect convergent evidence rather than isolated viewpoints. Analytical methods included qualitative coding of interview data, comparative feature mapping across instruments and consumables, and scenario analysis to assess the impact of supply chain and policy variables.

Throughout the research process, quality controls included cross-checking statements with independent experts, maintaining an audit trail for data sources, and transparently documenting assumptions and limitations. This methodological rigor supports confidence in the strategic recommendations and ensures that the research can be applied directly to product planning, commercial strategy, and operational decision-making.

A strategic wrap-up highlighting technological strengths, operational imperatives, and ecosystem levers required to mainstream nanopore sequencing effectively

In conclusion, nanopore single-molecule sequencing occupies a distinct and expanding niche within the broader genomics landscape, characterized by unique capabilities in long-read analysis, direct modification detection, and real-time data generation. Technological maturation, diversified instrument portfolios, and an evolving software ecosystem are lowering barriers to broader adoption across research, clinical, and field-deployable applications. However, successful scaling will depend on ecosystem-level coordination: robust consumable supply chains, validated workflows, regulatory readiness, and compelling commercial models that deliver predictable value to end users.

Operational resilience-especially in the face of tariff volatility and supply chain disruptions-remains a strategic imperative, as does investment in evidence generation to support clinical translation. Organizations that combine product innovation with strong service offerings, interoperable analytics, and targeted partnerships are best positioned to capture emerging opportunities. By pursuing pragmatic steps to align technology capabilities with customer workflows and regional dynamics, stakeholders can accelerate the transition of nanopore sequencing from a specialized research tool to a mainstream component of translational science and diagnostic practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nanopore Single Molecule Sequencer Market, by Product Type

  • 8.1. Consumable
    • 8.1.1. Flow Cells
    • 8.1.2. Kits
  • 8.2. Instrument
    • 8.2.1. Gridion
    • 8.2.2. Minion
    • 8.2.3. Promethion
  • 8.3. Software
    • 8.3.1. Analysis Software
    • 8.3.2. Cloud Solutions

9. Nanopore Single Molecule Sequencer Market, by Business Model

  • 9.1. Product Sales
  • 9.2. Service Contracts

10. Nanopore Single Molecule Sequencer Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Epigenomics
  • 10.3. Genomics
  • 10.4. Metagenomics
  • 10.5. Transcriptomics

11. Nanopore Single Molecule Sequencer Market, by End User

  • 11.1. Academic Government
  • 11.2. Biopharma Pharma
  • 11.3. Clinical Laboratories
  • 11.4. Contract Research Organizations

12. Nanopore Single Molecule Sequencer Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Nanopore Single Molecule Sequencer Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Nanopore Single Molecule Sequencer Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Nanopore Single Molecule Sequencer Market

16. China Nanopore Single Molecule Sequencer Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 10x Genomics, Inc.
  • 17.6. Agilent Technologies, Inc.
  • 17.7. BGI Genomics Co., Ltd.
  • 17.8. Bio-Rad Laboratories, Inc.
  • 17.9. Direct Genomics Co., Ltd.
  • 17.10. Eurofins Scientific SE
  • 17.11. F. Hoffmann-La Roche Ltd
  • 17.12. Genapsys, Inc.
  • 17.13. Hitachi High-Technologies Corporation
  • 17.14. Illumina, Inc.
  • 17.15. Microsynth AG
  • 17.16. Nabsys, Inc.
  • 17.17. Oxford Nanopore Technologies plc
  • 17.18. Pacific Biosciences of California, Inc.
  • 17.19. PerkinElmer, Inc.
  • 17.20. QIAGEN N.V.
  • 17.21. Quantum Biosystems Inc.
  • 17.22. SeqLL Inc.
  • 17.23. Stratos Genomics, Inc.
  • 17.24. Thermo Fisher Scientific Inc.
  • 17.25. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GRIDION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GRIDION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GRIDION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY MINION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY MINION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY MINION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PROMETHION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PROMETHION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PROMETHION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLOUD SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLOUD SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLOUD SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SERVICE CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SERVICE CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SERVICE CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ACADEMIC GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ACADEMIC GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY ACADEMIC GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BIOPHARMA PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BIOPHARMA PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BIOPHARMA PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 150. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 152. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 174. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 176. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. G7 NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 182. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 184. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. NATO NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY CONSUMABLE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY INSTRUMENT, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA NANOPORE SINGLE MOLECULE SEQUENCER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)